November 7, 2012 — Athera Biotechnologies AB announced that results from a new study were presented at the Pacific ...
Cath Lab
The catheterization lab channel includes content related to interventional technologies for coronary and peripheral artery disease (PAD). Other cath lab transcatheter device technologies covered on this page included percutaneous treatment for stroke, venous interventions, heart valves, hypertension, heart failure and percutenous coronary interventions (PCI).
November 6, 2012 — A study has found several benefits in using the radial artery in the arm as the entry point for ...
Hospitals constantly try to predict what the future holds when planning new facilities and equipment purchases that will ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
November 6, 2012 — Vascular Solutions launched the R-Band radial hemostasis compression device in the United States ...
Positive results from the RESPECT Trial of transcatheter patent foramen ovale (PFO) closure vs. standard medical therapy ...
November 5, 2012 — Edwards Lifesciences Corporation announced three-year results of a pivotal clinical study of ...
Adjustable parameters on the ACIST® CVI® Contrast Delivery System include, flow rate, volume, pressure limit, rise time ...
November 2, 2012 – A clinical trial that compared catheter-based PFO closure using an investigational device found that ...
November 2, 2012 — Patients who receive a drug-eluting stent (DES) and demonstrate low levels of platelet inhibition are ...
November 1, 2012 — Medtronic Inc. announced promising data from the Engager European Pivotal Trial for the ...
As medical advancements continue to push the boundaries of what is possible in the field of structural heart ...
November 1, 2012 — Terumo Interventional Systems announced the nationwide availability of its new Pinnacle Precision ...
November 1, 2012 — InspireMD Inc. announced that its proprietary MGuard embolic protection stent (EPS) was shown to be ...
October 31, 2012 — Boston Scientific Corp. received CE mark approval for the Synergy everolimus-eluting platinum ...
While the current positive revolution in percutaneous coronary intervention (PCI) practice has been made possible by the ...
October 30, 2012 — Maquet Cardiovascular received 510(k) clearance from the U.S. Food and Drug Administration (FDA) and ...
October 30, 2012 — W. L. Gore & Associates responded to initial results reported in St. Jude Medical Inc.’s RESPECT ...
October 30, 2012 — Fractional flow reserve (FFR)-guided treatment was shown to be cost effective for guiding coronary ...
November 07, 2012